Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 20NIH 3NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Sarcoma, Kaposi 1Sarcoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Graft vs Host Disease 1AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 11Rituximab 9fludarabine phosphate 7fludarabine 4Whole-Body Irradiation 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 4Methotrexate 4Alemtuzumab 4Tacrolimus 3Prednisone 3Melphalan 3Cytogenetic Analysis 3Busulfan 3Vincristine 2Pentostatin 2Patient Reported Outcome Measures 2Mesna 2In Situ Hybridization, Fluorescence 2Gene Expression Profiling 2Flow Cytometry 2Filgrastim 2Doxorubicin 2Bendamustine Hydrochloride 2ruxolitinib 1plerixafor 1pegfilgrastim 1merphos 1liposomal amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Leukemia, Lymphocytic, Chronic, B-Cell × Sirolimus × Clear all
NCT02793544 2025-08-06

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Center for International Blood and Marrow Transplant Research

Phase 2 Completed
80 enrolled 56 charts
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡